TREATMENT OF VASCULAR COGNITIVE IMPAIRMENT

EDITORIAL COMMENT
There is increasing evidence that small-vessel disease caused by high blood pressure in mid-life (Qiu et al ) leads to white matter changes on MRI and non-memory cognitive decline affecting information processing speed and executive function (Prins et al ). When the functional threshold for vascular dementia had been reached, donepezil was found effective in the combined analysis run by Román et al from two large pivotal placebocontrolled studies.

The age-dependent relation of blood pressure to cognitive function and dementia
(LANCET NEUROL 2005;4:487-499)

CHENGXUAN QIU,
BENGT WINBLAD,
LAURA FRATIGLIONI
STOCKHOLM, SWEDEN

Cerebral small-vessel disease and decline in information processing speed, executive function and memory
(BRAIN 2005;128:2034-2041)

NIELS D. PRINS,
EWOUD J. VAN DIJK,
TOM DEN HEIJER,
SARAH E. VERMEER,
ET AL,
ROTTERDAM,
MAASTRICHT, THE NETHERLANDS

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials
(DEMENT GERIATR COGN DISORD 2005;20:338-344)

GUSTAVO C. ROMÁN,
DAVID G, WILKINSON,
RACHELLE S. DOODY,
SANDRA E. BLACK,
ET AL
SAN ANTONIO, HOUSTON, TX
NEW YORK, NY,
SOUTHAMPTON, UK,

 

 

 

 

 

 

 

 

 
TREATMENT OF VASCULAR COGNITIVE IMPAIRMENT
MANAGEMENT OF MILD COGNITIVE IMPAIRMENT
NATURAL HISTORY OF PRIMARY PROGRESSIVE APHASIA
THERAPIES AND NEUROPROTECTION IN AD
ATYPICAL ANTIPSYCHOTICS FOR BPSD
DETRIMENTAL EFFECTS OF ANTICHOLINERGIC MEDICATIONS
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use